These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36912316)

  • 21. Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
    Park MR; Wang EH; Jin DC; Cha JH; Lee KH; Yang CW; Kang CS; Choi YJ
    Proteomics; 2006 Feb; 6(3):1066-76. PubMed ID: 16372274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography.
    Kalantari S; Rutishauser D; Samavat S; Nafar M; Mahmudieh L; Rezaei-Tavirani M; Zubarev RA
    PLoS One; 2013; 8(12):e80830. PubMed ID: 24339887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli.
    Dong J; Zheng F; Liu F; He J; Li S; Pu W; Xu H; Luo Z; Liu S; Yin L; Tang D; Dai Y
    Front Immunol; 2023; 14():1131164. PubMed ID: 37033921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic signature of tubulointerstitial tissue predicts prognosis in IgAN.
    Paunas FTI; Finne K; Leh S; Marti HP; Berven F; Vikse BE
    BMC Nephrol; 2022 Mar; 23(1):118. PubMed ID: 35331167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
    Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
    Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy.
    Obara T; Mizoguchi S; Shimozuru Y; Sato T; Hotta O
    Clin Exp Nephrol; 2012 Oct; 16(5):713-21. PubMed ID: 22415778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli.
    Paunas FTI; Finne K; Leh S; Osman TA; Marti HP; Berven F; Vikse BE
    BMC Nephrol; 2019 Nov; 20(1):410. PubMed ID: 31726998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. iTRAQ-based comparative proteomics analysis reveals specific urinary biomarkers for various kidney diseases.
    Jin J; Gong J; Zhao L; Li Y; Wang Y; He Q
    Biomark Med; 2020 Jul; 14(10):839-854. PubMed ID: 32856461
    [No Abstract]   [Full Text] [Related]  

  • 31. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
    Liu Y; Liu X; Jia J; Zheng J; Yan T
    J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
    Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T
    Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy.
    Li G; Wang X; Yang Z; Zhao Q; Wen Y; Li X; Gao R
    Dis Markers; 2019; 2019():9802839. PubMed ID: 31354895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
    Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
    Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
    Haubitz M; Wittke S; Weissinger EM; Walden M; Rupprecht HD; Floege J; Haller H; Mischak H
    Kidney Int; 2005 Jun; 67(6):2313-20. PubMed ID: 15882273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of mannose-binding lectin as a mechanism in progressive immunoglobulin A nephropathy.
    Shi B; Wang L; Mou S; Zhang M; Wang Q; Qi C; Cao L; Che X; Fang W; Gu L; Yan Y; Qian J; Ni Z
    Int J Clin Exp Pathol; 2015; 8(2):1889-99. PubMed ID: 25973081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice.
    Miyakawa R; Sato A; Matsuda Y; Saito A; Abe F; Matsumura H; Odaka M; Suzuki T; Dohmae N; Komatsuda A; Takahashi N; Wakui H
    Clin Exp Nephrol; 2020 Aug; 24(8):666-679. PubMed ID: 32436031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and monitoring of IgA nephropathy: the role of biomarkers as an alternative to renal biopsy.
    Moresco RN; Speeckaert MM; Delanghe JR
    Autoimmun Rev; 2015 Oct; 14(10):847-53. PubMed ID: 26026694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocytosis associated with IgA nephropathy.
    Cohen C; Coulon S; Bhukhai K; Neuraz A; Dussiot M; Fouquet G; Stang ML; Flamant M; Vrtovsnik F; Hummel A; Knebelmann B; Mesnard L; Rondeau E; Maciel TT; Favale F; Casadevall N; Nguyen-Khoa T; Moutereau S; Legendre C; Benhamou M; Monteiro RC; Hermine O; El Karoui K; Moura IC
    EBioMedicine; 2022 Jan; 75():103785. PubMed ID: 34959131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.